Log in
NASDAQ:AIMT

Aimmune Therapeutics SEC Filings & 10K Form

$34.49
0.00 (0.00 %)
(As of 10/13/2020)
Add
Compare
Today's Range
$34.49
Now: $34.49
$34.49
50-Day Range
$34.19
MA: $34.40
$34.59
52-Week Range
$10.09
Now: $34.49
$37.00
VolumeN/A
Average Volume1.71 million shs
Market Capitalization$2.26 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.76

SEC Filings

Aimmune Therapeutics (NASDAQ:AIMT) SEC Filings

DateFilerForm TypeView
10/23/2020
12:11 PM
Aimmune Therapeutics (Filer)
Form 15-12B
10/19/2020
4:05 PM
Aimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2020
6:18 PM
Aimmune Therapeutics (Issuer)
Societe des Produits Nestle S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
11:15 PM
Aimmune Therapeutics (Filer)
Form EFFECT
10/14/2020
11:15 PM
Aimmune Therapeutics (Filer)
Form EFFECT
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
Sheehy Douglas T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
MCDADE MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
Behar Gregory (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
HAUMANN BRETT K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
Seltzer Stacey Denenberg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
Iwicki Mark T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
ENRIGHT PATRICK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
ADELMAN DANIEL C MD (Reporting)
Aimmune Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2020
3:15 PM
Aimmune Therapeutics (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
4:31 PM
Aimmune Therapeutics (Filer)
Form S-8 POS
10/13/2020
4:29 PM
Aimmune Therapeutics (Filer)
Form S-8 POS
10/13/2020
4:29 PM
Aimmune Therapeutics (Filer)
Form S-8 POS
10/13/2020
4:29 PM
Aimmune Therapeutics (Filer)
Form S-8 POS
10/13/2020
4:29 PM
Aimmune Therapeutics (Filer)
Form POS AM
10/13/2020
4:28 PM
Aimmune Therapeutics (Filer)
Form S-8 POS
10/13/2020
4:28 PM
Aimmune Therapeutics (Filer)
Form S-8 POS
10/13/2020
4:28 PM
Aimmune Therapeutics (Filer)
Form POS AM
10/13/2020
10:12 AM
Aimmune Therapeutics (Subject)
Form SC 13E3/A
10/13/2020
10:09 AM
Aimmune Therapeutics (Subject)
Form SC 14D9/A
10/13/2020
9:48 AM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC 13D/A
10/13/2020
9:44 AM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC TO-T/A
10/13/2020
8:14 AM
Aimmune Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
10/08/2020
4:18 PM
Aimmune Therapeutics (Subject)
Form SC 14D9/A
10/05/2020
8:20 PM
ADELMAN DANIEL C MD (Reporting)
Aimmune Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
8:14 PM
Aimmune Therapeutics (Issuer)
Sheehy Douglas T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
8:13 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
4:26 PM
Aimmune Therapeutics (Subject)
Form SC 14D9/A
10/05/2020
4:24 PM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC TO-T/A
10/05/2020
5:06 AM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC TO-T/A
10/02/2020
3:14 PM
Aimmune Therapeutics (Subject)
Form SC 14D9/A
09/29/2020
5:18 AM
Aimmune Therapeutics (Subject)
Form SC 13E3/A
09/29/2020
5:15 AM
Aimmune Therapeutics (Subject)
Form SC 14D9/A
09/29/2020
5:07 AM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC TO-T/A
09/24/2020
4:15 PM
Aimmune Therapeutics (Subject)
Form SC 14D9/A
09/23/2020
8:35 PM
Aimmune Therapeutics (Issuer)
ENRIGHT PATRICK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2020
7:20 AM
Aimmune Therapeutics (Subject)
Form SC 13E3/A
09/21/2020
7:17 AM
Aimmune Therapeutics (Subject)
Form SC 14D9/A
09/21/2020
7:10 AM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC TO-T/A
09/16/2020
4:20 PM
Aimmune Therapeutics (Issuer)
Sheehy Douglas T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
4:19 PM
Aimmune Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
4:18 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
4:17 PM
Aimmune Therapeutics (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
4:17 PM
ADELMAN DANIEL C MD (Reporting)
Aimmune Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
4:29 PM
Aimmune Therapeutics (Subject)
Form SC 13E3
09/14/2020
4:27 PM
Aimmune Therapeutics (Subject)
Form SC 14D9
09/14/2020
4:16 PM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC TO-T
09/14/2020
6:33 AM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC TO-C
08/31/2020
5:49 AM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC TO-C
08/31/2020
5:47 AM
Aimmune Therapeutics (Subject)
Societe des Produits Nestle S.A. (Filed by)
Form SC 13D/A
08/31/2020
5:08 AM
Aimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2020
8:20 PM
Aimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/26/2020
4:06 PM
Aimmune Therapeutics (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
6:17 PM
Aimmune Therapeutics (Issuer)
Iwicki Mark T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
6:17 PM
Aimmune Therapeutics (Issuer)
Behar Gregory (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
6:17 PM
Aimmune Therapeutics (Issuer)
HAUMANN BRETT K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
6:15 PM
Aimmune Therapeutics (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
6:13 PM
Aimmune Therapeutics (Issuer)
ENRIGHT PATRICK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
6:13 PM
Aimmune Therapeutics (Issuer)
MCDADE MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
6:12 PM
Aimmune Therapeutics (Issuer)
Seltzer Stacey Denenberg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
3:50 PM
Aimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
4:25 PM
Aimmune Therapeutics (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
4:24 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
4:20 PM
Aimmune Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
4:15 PM
ADELMAN DANIEL C MD (Reporting)
Aimmune Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:14 PM
Aimmune Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
3:09 PM
Aimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2020
3:47 PM
Aimmune Therapeutics (Issuer)
Nestle Health Science US Holdings, Inc. (Reporting)
NESTLE SA (Reporting)
Nestle US Holdco, Inc. (Reporting)
NIMCO US, Inc. (Reporting)
Societe des Produits Nestle S.A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/24/2020
3:45 PM
Aimmune Therapeutics (Issuer)
Nestle Health Science US Holdings, Inc. (Reporting)
NESTLE SA (Reporting)
NIMCO US, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
4:07 PM
Aimmune Therapeutics (Filer)
Form DEFA14A
04/09/2020
4:03 PM
Aimmune Therapeutics (Filer)
Form DEF 14A
03/17/2020
3:51 PM
Aimmune Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
8:13 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
7:48 PM
Aimmune Therapeutics (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
7:47 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
8:53 PM
Aimmune Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4/A
03/04/2020
8:49 PM
Aimmune Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
8:42 PM
Aimmune Therapeutics (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
8:38 PM
Aimmune Therapeutics (Issuer)
Sheehy Douglas T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
8:36 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
8:34 PM
ADELMAN DANIEL C MD (Reporting)
Aimmune Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
7:37 PM
Aimmune Therapeutics (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
7:36 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
7:35 PM
ADELMAN DANIEL C MD (Reporting)
Aimmune Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
7:35 PM
Aimmune Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
7:30 PM
Aimmune Therapeutics (Issuer)
Sheehy Douglas T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
3:10 PM
Aimmune Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
4:26 PM
Aimmune Therapeutics (Issuer)
BJERKHOLT ERIC (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
4:23 PM
Aimmune Therapeutics (Issuer)
Rozenman Mary M. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
4:23 PM
Aimmune Therapeutics (Issuer)
Dallas Jayson Donald Alexander (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
4:23 PM
ADELMAN DANIEL C MD (Reporting)
Aimmune Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
12:16 PM
Aimmune Therapeutics (Subject)
Palo Alto Investors LP (Filed by)
Form SC 13G
02/12/2020
3:24 PM
Aimmune Therapeutics (Subject)
Longitude Capital Partners II, LLC (Filed by)
Form SC 13G/A
This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.